Searched for
ONCO THERAPIES
Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform globalPrecision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...- Biocon founder Kiran Mazumdar-Shaw backs two cancer startupsHer bet on UE’s iBreastExam device is based on the uncomfortable experience women face with mammograms. But Shaw calls UE’s scans “intellig...
- Antibiotics made by Emcure Pharmaceuticals recalled in USUSFDA said reason for recalls was lack of assurance of sterility and "firm is recalling two injectable products due to concerns with qualit...
- CCI gives green signal to Strides Arcolab-Mylan dealCCI has approved the acquisition of a Strides Arcolab subsidiary by Mylan, saying the deal will not have an adverse impact on competition i...
- Strides Arcolab gets USFDA approval for generic cancer drugCiting IMS data, Strides Arcolab said the US market for generic Ifosfamide is approximately $15 million.
- Strides Arcolab hits 52-week high on US FDA approval for Ifosfamide injectionStrides Arcolab Ltd surged over 2 per cent in trade on Thursday after Onco Therapies received ANDA approval for Ifosfamide Injection.
- Strides Arcolab gets final ANDA nod for Vinorelbine injectionStrides Arcolab 's wholly owned subsidiary Onco Therapies has received final ANDA approval for Vinorelbine injection.
- Strides Arcolab gets USFDA nod for cancer drugStrides Arcolab said its subsidiary has received USFDA American health regulator's approval to sell Vinorelbine injection, a cancer drug, i...
- Strides Arcolab unit gets US health regulator's nod for cancer drugStrides Arcolab said its subsidiary has received US health regulator's approval to mkt generic topotecan hydrochloride injection, a cancer ...
- Strides Arcolab gets FDA approval for Oxaliplatin injectionOnco Therapies Ltd, a wholly owned subsidiary of Strides Arcolab today announced that it has received final ANDA approval for Oxaliplatin i...
- Strides Arcolab gets USFDA nod for anti-cancer injectionStrides Arcolab today said it has received approvals from the US health regulator for generic Fluorouracil Injection used for treating seve...
- Strides Arcolab surge to record high on cancer drug approvalShares of drug maker Strides Arcolab today surged to a record high after the company received approval from the US health regulator to sell...
- Strides Arcolab gets USFDA nod for cancer injection CisplatinStrides Arcolab said it has received approval from the USFDA to sell generic version of Cisplatin injection used in cancer treatment.
- Strides Arcolab's arm Onco Therapies gets USFDA nod for cancer drug Methotrexate InjectionStrides Arcolab today said its subsidiary Onco Therapies received the US drug regulator's nod to sell cancer medicine Methotrexate Injectio...
- Strides receives USFDA approval for two cancer drugsDrug firm Strides Arcolab today said it has received approval from the US health regulator to market two generic cancer drugs in the Americ...
- Strides Arcolab receives USFDA nod for blood cancer injectionStrides Arcolab said its subsidiary Onco Therapies has received approval from the US health regulator to market its generic Cladribine inje...
- Strides Arcolab gets USFDA nod for cancer injectionDrug firm Strides Arcolab on Tuesday said its subsidiary has received approval from the US health regulator for the launch of Gemcitabine i...
- Strides Arcolab, US FDA, Polymyxin B, Onco TherapiesBangalore-based Strides Arcolab received European and US FDA approval on Friday for two of its products.
- Strides Arcolab gets approval for facility, anti-bacterial injectionDrug firm Strides Arcolab today said it has received approval from the European authorities for its Bangalore-based oncology facility.
- Strides Arcolab’s unit gets US FDA nod for oncology products; stock downOnco Therapies, a subsidiary of Strides Arcolab, has got US FDA approval for its oncology facility in Bangalore.
Load More
